NextCure
Latest round
- Series B
Last raised
- Nov 2018
Total raised
- $160M
Investors
- 15
About NextCure
NextCure, Inc.Founded in 2015 and headquartered in the United States, NextCure, Inc. specializes in immunomedicine development.NextCure, Inc. specializes in developing innovative immunomedicines aimed at addressing unmet medical needs in oncology and other immune-related disorders. Their primary offerings include proprietary antibody-based therapeutics designed to target key pathways involved in tumor progression and immune evasion, advancing through clinical trials in North America and Europe.71 mn reported for 2023.NextCure, Inc. The company is focused on launching new products that specifically target critical therapeutic areas in immunology and oncology, with strategic expansion plans into additional markets in North America and Europe.
Who invested in NextCure
15 investors across 2 rounds
See all investors in NextCure
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NextCure
Who invested in NextCure?
NextCure has 15 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NextCure raised?
NextCure has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did NextCure last raise money?
NextCure's most recent round on record is a Series B, in Nov 2018.
What does NextCure do?
NextCure is a pharmaceuticals company.
Where is NextCure headquartered?
NextCure is headquartered in US.
Which VCs invest in companies like NextCure?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at NextCure's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like NextCure? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.